Members Area
Members Area

Welcome Back,

Members Area
My Account

Medicines Safety

Training videos 2025

TPT in children and adolescents

Tuberculosis Infographics

Management of Paeds and Adol Tuberculosis Guideline

WARNING ABOUT INCREASED RISK OF CLEFT LIP AND/OR CLEFT PALATE FOLLOWING THE USE OF ZOFRAN® (ONDANSETRON) IN THE FIRST 12 WEEKS OF PREGNANCY.

WARNING ABOUT INCREASED RISK OF CLEFT LIP AND/OR CLEFT PALATE FOLLOWING THE USE OF ONDANSETRON IN THE FIRST 12 WEEKS OF PREGNANCY

FLUOROQUINOLONE ANTIBIOTICS – RISK OF MITRAL AND AORTIC REGURGITATION ASSOCIATED WITH THE USE OF ORAL AND INJECTABLE FLUOROQUINOLONES